The potential of protein disulfide isomerase as a therapeutic drug target

Oncology Research

Volumn 19, Issue 10-11, 2012, Pages 445-453

  Khan, Maola M G ^a,b   Simizu, Siro ^a,c   Kawatani, Makoto ^a   Osada, Hiroyuki ^a,b  

^a RIKEN   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Bacitracin; Inhibitor; Juniferdin; Protein disulfide isomerase

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ARSENOSOBENZENE; BACITRACIN; ESTRONE; PROTEIN DISULFIDE ISOMERASE; RIBOSTAMYCIN;

APOPTOSIS; CANCER INVASION; CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOPLASM; DISULFIDE BOND; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME STRUCTURE; GLIOMA; HUMAN; ISOMERIZATION; METASTASIS; NEOPLASM; NEUROLOGIC DISEASE; OXIDATION REDUCTION STATE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW;

EID: 84859711349     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504011X13123323849717     Document Type: Review

References (64)

1. Ellgaard, L.; Ruddock, L. W. The human protein disulphide isomerase family: Substrate interactions and functional properties. EMBO Rep. 6:28-32; 2005.
2. Alanen, H. I.; Williamson, R. A.; Howard, M. J.; Hatahet, F. S.; Salo, K. E.; Kauppila, A.; et al. ERp27, a new non-catalytic endoplasmic reticulum-located human protein disulfide isomerase family member, interacts with ERp57. J. Biol. Chem. 281:33727-33738; 2006.
3. Haugstetter, J.; Maurer, M. A.; Blicher, T.; Pagac, M.; Wider, G.; Ellgaard, L. Structure-function analysis of the endoplasmic reticulum oxidoreductase TMX3 reveals interdomain stabilization of the N-terminal redox-active domain. J. Biol. Chem. 282:33859-33867; 2007.
4. Sugiura, Y.; Araki, K.; Iemura, S.; Natsume, T.; Hoseki, J.; Nagata, K. Novel thioredoxin-related transmembrane protein TMX4 has reductase activity. J. Biol. Chem. 285:7135-7142; 2010.
5. Goldberger, R. F.; Epstein, C. J.; Anfinsen, C. B. Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver. J. Biol. Chem. 238:628-635; 1963.
6. Kaiser, B. K.; Yim, D.; Chow, I. T.; Gonzalez, S.; Dai, Z.; Mann, H. H.; et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447:482-486; 2007.
7. Tager, M.; Kroning, H.; Thiel, U.; Ansorge, S. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Exp. Hematol. 25:601-607; 1997.
8. Jordan, P. A.; Gibbins, J. M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal. 8:312-324; 2006.
9. Freedman, R. B. Protein disulfide isomerase: Multiple roles in the modification of nascent secretory proteins. Cell 57:1069-1072; 1989.
10. Frand, A. R.; Cuozzo, J. W.; Kaiser, C. A. Pathways for protein disulphide bond formation. Trends Cell Biol. 10:203-210; 2000.
11. Mandel, R.; Ryser, H. J.; Ghani, F.; Wu, M.; Peak, D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc. Natl. Acad. Sci. USA 90:4112-4116; 1993.
12. Zhang, L. M.; St Croix, C.; Cao, R.; Wasserloos, K.; Watkins, S. C.; Stevens, T.; et al. Cell-surface protein disulfide isomerase is required for transnitrosation of metallothionein by S-nitroso-albumin in intact rat pulmonary vascular endothelial cells. Exp. Biol. Med. (Maywood). 231:1507-1515; 2006.
13. Ramachandran, N.; Root, P.; Jiang, X. M.; Hogg, P. J.; Mutus, B. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc. Natl. Acad. Sci. USA 98:9539-9544; 2001.
14. Hatahet, F.; Ruddock, L. W. Modulating proteostasis: Peptidomimetic inhibitors and activators of protein folding. Curr. Pharm. Des. 15:2488-2507; 2009.
15. Khan, M. M.; Simizu, S.; Lai, N. S.; Kawatani, M.; Shimizu, T.; Osada, H. Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. ACS Chem. Biol. 6:245-251; 2011.
16. Gruber, C. W.; Cemazar, M.; Heras, B.; Martin, J. L.; Craik, D. J. Protein disulfide isomerase: The structure of oxidative folding. Trends. Biochem. Sci. 31:455-464; 2006.
17. Wilkinson, B.; Gilbert, H. F. Protein disulfide isomerase. Biochim. Biophys. Acta 1699:35-44; 2004.
18. Hatahet, F.; Ruddock, L. W. Protein disulfide isomerase: A critical evaluation of its function in disulfide bond formation. Antioxid. Redox Signal. 11:2807-2850; 2009.
19. Schwaller, M.; Wilkinson, B.; Gilbert, H. F. Reduction-reoxidation cycles contribute to catalysis of disulfide isomerization by protein-disulfide isomerase. J. Biol. Chem. 278:7154-7159; 2003.
20. Puig, A.; Gilbert, H. F. Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. J. Biol. Chem. 269:7764-7771; 1994.
21. Wang, C. C.; Tsou, C. L. Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J. 7:1515-1517; 1993.
22. Cai, H.; Wang, C. C.; Tsou, C. L. Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds. J. Biol. Chem. 269:24550-24552; 1994.
23. Song, J. L.; Wang, C. C. Chaperone-like activity of protein disulfide-isomerase in the refolding of rhodanese. Eur. J. Biochem. 231:312-316; 1995.
24. Primm, T. P.; Walker, K. W.; Gilbert, H. F. Facilitated protein aggregation. Effects of calcium on the chaperone and anti-chaperone activity of protein disulfide-isomerase. J. Biol. Chem. 271:33664-33669; 1996.
25. Pirneskoski, A.; Klappa, P.; Lobell, M.; Williamson, R. A.; Byrne, L.; Alanen, H. I.; et al. Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J. Biol. Chem. 279:10374-10381; 2004.
26. Darby, N. J.; Creighton, T. E. Functional properties of the individual thioredoxin-like domains of protein disulfide isomerase. Biochemistry 34:11725-11735; 1995.
27. Darby, N. J.; Penka, E.; Vincentelli, R. The multi-domain structure of protein disulfide isomerase is essential for high catalytic efficiency. J. Mol. Biol. 276:239-247; 1998.
28. Koivunen, P.; Pirneskoski, A.; Karvonen, P.; Ljung, J.; Helaakoski, T.; Notbohm, H.; et al. The acidic C-terminal domain of protein disulfide isomerase is not critical for the enzyme subunit function or for the chaperone or disulfide isomerase activities of the polypeptide. EMBO J. 18:65-74; 1999.
29. Lyles, M. M.; Gilbert, H. F. Mutations in the thioredoxin sites of protein disulfide isomerase reveal functional non-equivalence of the N- and C-terminal domains. J. Biol. Chem. 269:30946-3052; 1994.
30. Quan, H.; Fan, G.; Wang, C. C. Independence of the chap- erone activity of protein disulfide isomerase from its thioredoxin- like active site. J. Biol. Chem. 270:17078-17080; 1995.
31. Dai, Y.; Wang, C. A mutant truncated protein disulfide isomerase with no chaperone activity. J. Biol. Chem. 272:27572-27576; 1997.
32. Markovic, I.; Stantchev, T. S.; Fields, K. H.; Tiffany, L. J.; Tomic, M.; Weiss, C. D.; et al. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood 103:1586-1594; 2004.
33. Ryser, H. J.; Levy, E. M.; Mandel, R.; DiSciullo, G. J. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc. Natl. Acad. Sci. USA 91:4559-4563; 1994.
34. Goplen, D.; Wang, J.; Enger, P. O.; Tysnes, B. B.; Terzis, A. J.; Laerum, O. D.; et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res. 66:9895-9902; 2006.
35. Lovat, P. E.; Corazzari, M.; Armstrong, J. L.; Martin, S.; Pagliarini, V.; Hill, D.; et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res. 68:5363-5369; 2008.
36. Root, P.; Sliskovic, I.; Mutus, B. Platelet cell-surface protein disulphide-isomerase mediated S-nitrosoglutathione consumption. Biochem. J. 382:575-580; 2004.
37. Orlandi, P. A. Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J. Biol. Chem. 272:4591-4599; 1997.
38. Abromaitis, S.; Stephens, R. S. Attachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase. PLoS Pathog. 5:e1000357; 2009.
39. Ryser, H. J.; Mandel, R.; Ghani, F. Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J. Biol. Chem. 266:18439-18442; 1991.
40. Gallina, A.; Hanley, T. M.; Mandel, R.; Trahey, M.; Broder, C. C.; Viglianti, G. A.; et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277:50579-50588; 2002.
41. Ryser, H. J.; Fluckiger, R. Progress in targeting HIV-1 entry. Drug Discov. Today. 10:1085-1094; 2005.
42. Finnegan, C.; Blumenthal, R. Dissecting HIV fusion: Identifying novel targets for entry inhibitors. Infect. Disord. Drug Targets. 6:355-367; 2006.
43. Berger, E. A.; Murphy, P. M.; Farber, J. M. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700; 1999.
44. Carta, F.; Demuro, P. P.; Zanini, C.; Santona, A.; Castiglia, D.; D'Atri, S.; et al. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res. 15:235-244; 2005.
45. Zhou, M.; Jacob, A.; Ho, N.; Miksa, M.; Wu, R.; Maitra, S. R.; et al. Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release. Crit. Care 12:R100; 2008.
46. Alaiya, A. A.; Al-Mohanna, M.; Aslam, M.; Shinwari, Z.; Al-Mansouri, L.; Al-Rodayan, M.; et al. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int. J. Oncol. 38:1047-1057; 2011.
47. Buhrens, R. I.; Amelung, J. T.; Reymond, M. A.; Beshay, M. Protein expression in human non-small cell lung cancer: A systematic database. Pathobiology 76:277-285; 2009.
48. Thongwatchara, P.; Promwikorn, W.; Srisomsap, C.; Chokchaichamnankit, D.; Boonyaphiphat, P.; Thongsuksai, P. Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol. Rep. 26:185-191; 2011.
49. Bartkowiak, K.; Effenberger, K. E.; Harder, S.; Andreas, A.; Buck, F.; Peter-Katalinic, J.; et al. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. J. Proteome Res. 9:3158-3168; 2010.
50. Bass, R.; Edwards, D. R. ADAMs and protein disulfide isomerase: The key to regulated cell-surface protein ectodomain shedding? Biochem. J. 428:e3-5; 2010.
51. Willems, S. H.; Tape, C. J.; Stanley, P. L.; Taylor, N. A.; Mills, I. G.; Neal, D. E.; et al. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 428:439-450; 2010.
52. Gregersen, N. Protein misfolding disorders: Pathogenesis and intervention. J. Inherit. Metab. Dis. 29:456-470; 2006.
53. Hoffstrom, B. G.; Kaplan, A.; Letso, R.; Schmid, R. S.; Turmel, G. J.; Lo, D. C.; et al. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat. Chem. Biol. 6:900-906; 2010.
54. Roth, R. A. Bacitracin: An inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem. Biophys. Res. Commun. 98:431-438; 1981.
55. Dickerhof, N.; Kleffmann, T.; Jack, R.; McCormick, S. Bacitracin inhibits the reductive activity of protein disulfide isomerase by forming a disulfide bond with free cysteines in the substrate binding domain. FEBS J. 278:2034-2043; 2011.
56. Karala, A. R.; Ruddock, L. W. Bacitracin is not a specific inhibitor of protein disulfide isomerase. FEBS J. 277:2454-2462; 2010.
57. Rogelj, S.; Reiter, K. J.; Kesner, L.; Li, M.; Essex, D. Enzyme destruction by a protease contaminant in bacitracin. Biochem. Biophys. Res. Commun. 273:829-832; 2000.
58. Horibe, T.; Nagai, H.; Sakakibara, K.; Hagiwara, Y.; Kikuchi, M. Ribostamycin inhibits the chaperone activity of protein disulfide isomerase. Biochem. Biophys. Res. Commun. 289:967-972; 2001.
59. Ou, W.; Silver, J. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. Virology 350:406-417; 2006.
60. Lara, H. H.; Ixtepan-Turrent, L.; Garza-Trevino, E. N.; Flores-Tevino, S. M.; Borkow, G.; Rodriguez-Padilla, C. Antiviral propierties of 5,5?-dithiobis-2-nitrobenzoic acid and bacitracin against T-tropic human immunodeficiency virus type 1. Virol. J. 8:137; 2011.
61. Tsibris, J. C.; Hunt, L. T.; Ballejo, G.; Barker, W. C.; Toney, L. J.; Spellacy, W. N. Selective inhibition of protein disulfide isomerase by estrogens. J. Biol. Chem. 264:13967-13970; 1989.
62. Primm, T. P.; Gilbert, H. F. Hormone binding by protein disulfide isomerase, a high capacity hormone reservoir of the endoplasmic reticulum. J. Biol. Chem. 276:281-286; 2001.
63. Guthapfel, R.; Gueguen, P.; Quemeneur, E. Reexamination of hormone-binding properties of protein disulfide-isomerase. Eur. J. Biochem. 242:315-319; 1996.
64. Fu, X.; Wang, P.; Zhu, B. T. Protein disulfide isomerase is a multifunctional regulator of estrogenic status in target cells. J. Steroid Biochem. Mol. Biol. 112:127-137; 2008.